134 related articles for article (PubMed ID: 33866343)
1. A case of progressive pulmonary alveolar proteinosis with lymphadenopathy revealed on
Xiao L; Zhu H; Zhang W; Li L
Hell J Nucl Med; 2021; 24(1):94-95. PubMed ID: 33866343
[TBL] [Abstract][Full Text] [Related]
2. (18)F-FDG and (18)F-FLT PET/CT imaging in the characterization of mediastinal lymph nodes.
Rayamajhi SJ; Mittal BR; Maturu VN; Agarwal R; Bal A; Dey P; Shukla J; Gupta D
Ann Nucl Med; 2016 Apr; 30(3):207-16. PubMed ID: 26661845
[TBL] [Abstract][Full Text] [Related]
3. Localized Airspace Consolidation of Pulmonary Alveolar Proteinosis Mimicking Malignant Lesions in 18F-FDG PET/CT Imaging: One Case Report.
Wang YL; Fang N; Zeng L; Wu ZJ; Cui XJ
Clin Nucl Med; 2015 Nov; 40(11):908-9. PubMed ID: 26252337
[TBL] [Abstract][Full Text] [Related]
4. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
5. Endobronchial ultrasound-guided transbronchial needle aspiration of hilar and mediastinal lymph nodes detected on 18F-fluorodeoxyglucose positron emission tomography/computed tomography.
Minami D; Takigawa N; Oda N; Ninomiya T; Kubo T; Ohashi K; Sato A; Hotta K; Tabata M; Kaji M; Tanimoto M; Kiura K
Jpn J Clin Oncol; 2016 Jun; 46(6):529-33. PubMed ID: 27004902
[TBL] [Abstract][Full Text] [Related]
6. F-18 FDG PET/CT in pulmonary alveolar proteinosis.
Hsu CW; Liu FY; Wang CW; Lin HC; Huang CD
Clin Nucl Med; 2009 Feb; 34(2):103-4. PubMed ID: 19352264
[No Abstract] [Full Text] [Related]
7. CT features of pulmonary alveolar proteinosis.
Holbert JM; Costello P; Li W; Hoffman RM; Rogers RM
AJR Am J Roentgenol; 2001 May; 176(5):1287-94. PubMed ID: 11312196
[TBL] [Abstract][Full Text] [Related]
8. [Pulmonary alveolar proteinosis].
Pensa LA; Solernó MR; Rausch S; Aruj PK; Grinberg AR
Medicina (B Aires); 2021; 81(2):301-303. PubMed ID: 33906153
[TBL] [Abstract][Full Text] [Related]
9. The diagnostic ability of
Lee JW; Kim EY; Kim DJ; Lee JH; Kang WJ; Lee JD; Yun M
Eur Radiol; 2016 Dec; 26(12):4515-4523. PubMed ID: 26943133
[TBL] [Abstract][Full Text] [Related]
10. Detection of Lymph Node Metastasis in Patients with Bladder Cancer using Maximum Standardised Uptake Value and
Vind-Kezunovic S; Bouchelouche K; Ipsen P; Høyer S; Bell C; Bjerggaard Jensen J
Eur Urol Focus; 2019 Jan; 5(1):90-96. PubMed ID: 28753817
[TBL] [Abstract][Full Text] [Related]
11. [A case of idiopathic pulmonary alveolar proteinosis with multiple localized ground-glass opacities].
Taniguchi H; Abo H; Touge M; Shinnou H; Miyazawa H; Noto H; Uchiyama A; Miwa A; Shimura S; Izumi S
Arerugi; 2008 Aug; 57(8):1061-6. PubMed ID: 18781111
[TBL] [Abstract][Full Text] [Related]
12. Preliminary clinical assessment of dynamic
Shinya T; Otomi Y; Kubo M; Kinoshita M; Takechi K; Uyama N; Yamanaka M; Terazawa K; Toba H; Bando Y; Otsuka H; Harada M
Ann Nucl Med; 2019 Jun; 33(6):414-423. PubMed ID: 30911883
[TBL] [Abstract][Full Text] [Related]
13. Is SUVmax Helpful in the Differential Diagnosis of Enlarged Mediastinal Lymph Nodes? A Pilot Study.
Yu C; Xia X; Qin C; Sun X; Zhang Y; Lan X
Contrast Media Mol Imaging; 2018; 2018():3417190. PubMed ID: 30510493
[TBL] [Abstract][Full Text] [Related]
14. Improved detection of metastatic lymph nodes in oesophageal squamous cell carcinoma by combined interpretation of fluorine-18-fluorodeoxyglucose positron-emission tomography/computed tomography.
Lee JY; Kim YH; Park YJ; Park SB; Chung HW; Zo JI; Shim YM; Lee KS; Choi JY
Cancer Imaging; 2019 Jun; 19(1):40. PubMed ID: 31227017
[TBL] [Abstract][Full Text] [Related]
15. Subtype-Guided
Wu S; Wang Y; Li J; Zhang N; Mo M; Klimberg S; Kaklamani V; Cochet A; Shao Z; Cheng J; Liu G
Oncologist; 2020 Apr; 25(4):e626-e633. PubMed ID: 32297448
[TBL] [Abstract][Full Text] [Related]
16. [A case of pulmonary alveolar proteinosis that showed solitary ground-glass opacity in the subpleural area].
Sunadome H; Nohara J; Noguchi T; Matsui C; Kono T; Terada Y
Nihon Kokyuki Gakkai Zasshi; 2010 Jul; 48(7):516-9. PubMed ID: 20684216
[TBL] [Abstract][Full Text] [Related]
17. Prognostic implication of fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography in patients with recurrent papillary thyroid cancer.
Kang JH; Jung DW; Pak KJ; Kim IJ; Kim HJ; Cho JK; Shin SC; Wang SG; Lee BJ
Head Neck; 2018 Jan; 40(1):94-102. PubMed ID: 29130586
[TBL] [Abstract][Full Text] [Related]
18. Detection of internal mammary lymph node metastasis with (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in patients with stage III breast cancer.
Seo MJ; Lee JJ; Kim HO; Chae SY; Park SH; Ryu JS; Ahn SH; Lee JW; Son BH; Gong GY; Moon DH
Eur J Nucl Med Mol Imaging; 2014 Mar; 41(3):438-45. PubMed ID: 24196918
[TBL] [Abstract][Full Text] [Related]
19. Differentiation of sarcoidosis-lymphoma syndrome lesions: a case report on the use of two different positron emission tomography tracers.
Yudistiro R; Arisaka Y; Tokue A; Nakajima T
BMC Med Imaging; 2016 Jan; 16():1. PubMed ID: 26746426
[TBL] [Abstract][Full Text] [Related]
20. Accuracy of F-18 FDG PET/CT with optimal cut-offs of maximum standardized uptake value according to size for diagnosis of regional lymph node metastasis in patients with rectal cancer.
Bae SU; Won KS; Song BI; Jeong WK; Baek SK; Kim HW
Cancer Imaging; 2018 Sep; 18(1):32. PubMed ID: 30217167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
